Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,984 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial.
Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S. Kudo A, et al. Among authors: ichikawa y. J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):487-499. doi: 10.1002/jhbp.1101. Epub 2021 Dec 27. J Hepatobiliary Pancreat Sci. 2022. PMID: 34907652 Clinical Trial.
Neuroendocrine tumor theranostics.
Ichikawa Y, Kobayashi N, Takano S, Kato I, Endo K, Inoue T. Ichikawa Y, et al. Cancer Sci. 2022 Jun;113(6):1930-1938. doi: 10.1111/cas.15327. Epub 2022 Apr 11. Cancer Sci. 2022. PMID: 35271754 Free PMC article. Review.
[A case of post-operative recurrence of pancreatic cancer in the residual pancreas treated by resection of the residual pancreas following radiological complete response achieved with second-line FOLFIRINOX].
Kobayashi N, Shimamura T, Tokuhisa M, Goto A, Mori R, Matsuyama R, Taniguchi K, Tanaka K, Akiyama H, Endo I, Ichikawa Y. Kobayashi N, et al. Among authors: ichikawa y. Gan To Kagaku Ryoho. 2014 Jul;41(7):901-4. Gan To Kagaku Ryoho. 2014. PMID: 25131881 Japanese.
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.
Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y. Kobayashi N, et al. Among authors: ichikawa y. Ann Nucl Med. 2021 Dec;35(12):1332-1341. doi: 10.1007/s12149-021-01674-9. Epub 2021 Sep 17. Ann Nucl Med. 2021. PMID: 34533700 Free PMC article.
1,984 results